Wild Tobacco Nicotine Biosynthesis Pathway Mapped
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Prof. LI Dapeng and colleagues at the Chinese Academy of Sciences' Center for Excellence in Molecular Plant Sciences published the complete nicotine biosynthetic pathway in Cell, using an information theory-guided multidimensional omics approach in the wild tobacco species Nicotiana attenuata.
- The researchers identified a nicotine-free mutant called ao2, which led to discovery of the NaAO2 gene essential for forming nicotine's pyridine ring.
- The team characterized a five-component dynamic metabolon — a glycosyltransferase (NaUGT1), a reductase (NaA622), berberine bridge enzyme-like enzymes (NaBBL1/2), β-glucosidases (NaBGL1/2), and a MATE transporter (NaMATE1) — that assembles at the vacuolar membrane to carry out the final condensation and transport steps.
- Plants use a cryptic "glycosylation/deglycosylation" strategy for coupling nicotine's 5- and 6-membered nitrogen-containing rings, involving two cyclic cation intermediates, a stereoselective Mannich-like condensation, and sequential oxidation to yield chirally pure nicotine stored in the vacuole.
- The metabolon assembly enables efficient substrate channeling and prevents toxic intermediate buildup, circumventing the "autotoxicity dilemma" that comes with producing a potent insecticide for self-defense.
- The discovery establishes a new synthetic biology paradigm for scalable production of high-value natural products with defined stereochemistry and provides critical insights into the Mannich-like reaction underlying scaffold formation in many plant alkaloids.
- Nicotine has been used as a pesticide since 1690 and has therapeutic potential for Alzheimer's disease, Parkinson's disease, and depression, the researchers note.
Why it matters: This completes a 300-plus-year-old puzzle (nicotine's first documented agricultural use dates to 1690) and gives synthetic biologists a five-enzyme template for engineering stereochemically pure alkaloid production. The metabolon architecture — enzymes clustering at the vacuolar membrane to avoid self-poisoning — could be replicated for other high-value plant natural products, potentially accelerating pharmaceutical research into neurological disorders.
